EW
SHOW DAILY
49
predicted that it will be soon.
"There are cases where it makes all
the difference in the world," he said.
"By using this new technology
and good preparation, these cases
can have a happy ending," Dr. Osher
said.
The presentation also high-
lighted the use of Alcon's new
nonsteroidal anti-inflammatory
drug Ilevro (nepafenac ophthalmic
suspension 0.3%) and the steroid
Durezol (difluprednate ophthalmic
emulsion).
"Live Cataract Surgery" was part
of EyeWorld Corporate Mornings. EW
Editors' note: This program was
sponsored by Alcon.
ASCRS•ASOA SYMPOSIUM & CONGRESS, BOSTON 2014
Attendees watch live surgery during Saturday's EyeWorld Corporate Morning event sponsored by Alcon.
